MGMT inactivation and clinical response in newly diagnosed GBM patients treated with Gliadel-Reference-Cited by-同舟云学术

MGMT inactivation and clinical response in newly diagnosed GBM patients treated with Gliadel

Published:2015-12 Issue:12 Volume:22 Page:1938-1942
ISSN:0967-5868
Container-title:Journal of Clinical Neuroscience
language:en
Short-container-title:Journal of Clinical Neuroscience

Author:

Grossman Rachel,Burger Peter,Soudry Ethan,Tyler Betty^ORCID,Chaichana Kaisorn L.,Weingart Jon,Olivi Alessandro,Gallia Gary L.,Sidransky David,Quiñones-Hinojosa Alfredo,Ye Xiaobu,Brem Henry

Publisher

Elsevier BV

Subject

Physiology (medical),Clinical Neurology,Neurology,General Medicine,Surgery

Reference18 articles.

1. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

2. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group;Brem;Lancet,1995

3. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma;Westphal;Neuro Oncol,2003

4. Pharmacokinetics of the carmustine implant;Fleming;Clin Pharmacokinet,2002

5. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain;Fung;Cancer Res,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?;International Journal of Molecular Sciences;2023-03-02

2. Role of Extracellular Vesicles in Glioma Progression: Deciphering Cellular Biological Processes to Clinical Applications;Current Topics in Medicinal Chemistry;2021-05-03

3. Current FDA-Approved Therapies for High-Grade Malignant Gliomas;Biomedicines;2021-03-22

4. A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma;Nature Biomedical Engineering;2020-09-28

5. Pharmaceutical implants: classification, limitations and therapeutic applications;Pharmaceutical Development and Technology;2019-11-12